Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
Cells|April 5, 2020
Platelet-Leukocyte Interplay in Cancer Development and ProgressionDagmar Stoiber, Alice AssingerLeukemia & Lymphoma|April 30, 2021
Tumor suppressors in acute myeloid leukemiaJacqueline Wallwitz, Petra Aigner, Dagmar StoiberFrontiers in Immunology|April 15, 2017
Type I Interferons and Natural Killer Cell Regulation in CancerLena Müller, Petra Aigner, Dagmar StoiberCytokine|July 23, 2018
STAT3 isoforms: Alternative fates in cancer?Petra Aigner, Valentin Just, Dagmar StoiberFrontiers in Bioscience (Landmark Edition)|May 31, 2011
Tyrosine kinase 2 (TYK2) in cytokine signalling and host immunityBirgit Strobl, Dagmar Stoiber, Veronika Sexl, et al.Methods in Molecular Biology (Clifton, N.J.)|February 1, 2015
Methods to study tumor surveillance using tumor cell transplantation into genetically engineered miceEva Bauer, Agnieszka Witalisz, Birgit Strobl, et al.Biomedicines|August 27, 2021
The Ups and Downs of STAT Inhibition in Acute Myeloid LeukemiaBernhard Moser, Sophie Edtmayer, Agnieszka Witalisz-Siepracka, et al.Cancers|June 2, 2021
Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors-A Strategy for Hematological Malignancies?Klara Klein, Dagmar Stoiber, Veronika Sexl, et al.Frontiers in Immunology|July 22, 2022
The Multifaceted Role of STAT3 in NK-Cell Tumor SurveillanceAgnieszka Witalisz-Siepracka, Klara Klein, Bernhard Zdársky, et al.Plos One|August 13, 2019
Validation of an enzyme-linked immunosorbent assay (ELISA) for quantification of endostatin levels in mice as a biomarker of developing glomerulonephritisJacqueline Wallwitz, Petra Aigner, Elisabeth Gadermaier, et al.Pageof 7